{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:31:07Z","timestamp":1762608667574},"reference-count":28,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2022,9,30]]},"DOI":"10.7883\/yoken.jjid.2021.795","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:16:42Z","timestamp":1648678602000},"page":"454-460","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of the Diagnostic Value of FliD, a &lt;i&gt;Helicobacter pylori&lt;\/i&gt; Flagellar Protein"],"prefix":"10.7883","volume":"75","author":[{"given":"Luo","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Tianjin Medical University General Hospital, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tianjin Haihe Hospital, Key Research Laboratory for Infectious Disease Prevention for State Administration of Traditional Chinese Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang Xiao","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tianjin Medical University General Hospital, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gu Dong","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tianjin Medical University General Hospital, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang Wei","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tianjin Medical University General Hospital, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan Chun","family":"Hui","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Wuhan Children\u2019s Hospital, Huazhong University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Malfertheiner P, Megraud F, OMorain CA, et al. Management of <i>Helicobacter pylori<\/i> infection\u2e3bthe Maastricht V\/Florence consensus report. Gut. 2017;66:6-30.","DOI":"10.1136\/gutjnl-2016-312288"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Xie C, Lu NH. Review: clinical management of <i>Helicobacter pylori<\/i> infection in China. Helicobacter. 2015;20:1-10.","DOI":"10.1111\/hel.12178"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kao CY, Sheu BS, Wu JJ. <i>Helicobacter pylori<\/i> infection: an overview of bacterial virulence factors and pathogenesis. Biomed J. 2016;39:14-23.","DOI":"10.1016\/j.bj.2015.06.002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Czinn SJ, Blanchard T. Vaccinating against <i>Helicobacter pylori<\/i> infection. Nat Rev Gastroenterol Hepatol. 2011;8:133-140.","DOI":"10.1038\/nrgastro.2011.1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Malfertheiner P, Selgrad M, Wex T, et al. Efficacy, immunogenicity, and safety of a parenteral vaccine against <i>Helicobacter pylori<\/i> in healthy volunteers challenged with a cag-positive strain: a randomised, placebo-controlled phase 1\/2 study. Lancet Gastroenterol Hepatol. 2018;3:698-707.","DOI":"10.1016\/S2468-1253(18)30125-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Zeng M, Mao XH, Li JX, et al. Efficacy, safety, and immunogenicity of an oral recombinant <i>Helicobacter pylori <\/i>vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2015;386:1457-1464.","DOI":"10.1016\/S0140-6736(15)60310-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pohl D, Keller PM, Bordier V, et al. Review of current diagnostic methods and advances in <i>Helicobacter pylori<\/i> diagnostics in the era of next generation sequencing. World J Gastroenterol. 2019;25:4629-4660.","DOI":"10.3748\/wjg.v25.i32.4629"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Osaki T, Mabe K, Hanawa T, et al. Urease-positive bacteria in the stomach induce a false-positive reaction in a urea breath test for diagnosis of <i>Helicobacter pylori<\/i> infection. J Med Microbiol. 2008;57:814-819.","DOI":"10.1099\/jmm.0.47768-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gu H. Role of flagella in the pathogenesis of <i>Helicobacter pylori<\/i>. Curr Microbiol. 2017;74:863-869.","DOI":"10.1007\/s00284-017-1256-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tang RX, Luo DJ, Sun AH, et al. Diversity of <i>Helicobacter pylori <\/i>isolates in expression of antigens and induction of antibodies. World J Gastroenterol. 2008;14:4816-4822.","DOI":"10.3748\/wjg.14.4816"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kim JS, Chang JH, Chung SI, et al. Molecular cloning and characterization of the <i>Helicobacter pylori fliD<\/i> gene, an essential factor in flagellar structure and motility. J Bacteriol. 1999;181:6969-6976.","DOI":"10.1128\/JB.181.22.6969-6976.1999"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Khalifeh Gholi M, Kalali B, Formichella L, et al. <i>Helicobacter pylori<\/i> FliD protein is a highly sensitive and specific marker for serologic diagnosis of <i>H. pylori<\/i> infection. Int J Med Microbiol. 2013;303:618-623.","DOI":"10.1016\/j.ijmm.2013.08.005"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Li H, Zhang B, Hu X, et al. Serum <i>Helicobacter pylori<\/i> FliD antibody and the risk of gastric cancer. Oncotarget. 2016;7:22397-22408.","DOI":"10.18632\/oncotarget.7981"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Zhang H, Yue R, Zhao P, et al. Proinflammatory follicular helper T cells promote immunoglobulin G secretion, suppress regulatory B cell development, and correlate with worse clinical outcomes in gastric cancer. Tumour Biol. 2017;39:1010428317705747.","DOI":"10.1177\/1010428317705747"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. da Silva-Etto JMK, Mattar R, Villares-Lopes CA, et al. Evaluation of diagnostic accuracy of two rapid stool antigen tests using an immunochromatographic assay to detect <i>Helicobacter pylori<\/i>. Clin Biochem. 2017;50:959-962.","DOI":"10.1016\/j.clinbiochem.2017.05.005"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gao S, Song D, Liu Y, et al. <i>Helicobacter pylori<\/i> cagA protein attenuates 5-Fu sensitivity of gastric cancer cells through upregulating cellular glucose metabolism. Onco Targets Ther. 2020;13:6339-6349.","DOI":"10.2147\/OTT.S230875"},{"key":"17","unstructured":"17. Hassan MA, Ahmed EH, Abdel-Raady BA, et al. Evaluation of non invasive versus invasive methods for diagnosis of <i>Helicobacter pylori<\/i> infection among patients with gastroduodenal disorders. Egypt J Immunol. 2016;23:39-49."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ayala G, Torres-Mena J, L\u00f3pez-Carrillo L. Association between <i>Helicobacter pylori<\/i> vacA antigens and gastric cancer depends on the detection method used: immunoblot versus neutralization of the vacuolating activity of vacA. J Med Microbiol. 2008;57:9-14.","DOI":"10.1099\/jmm.0.47550-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Fern\u00e1ndez-de-Larrea N, Michel A, Romero B, et al. Antibody reactivity against <i>Helicobacter pylori<\/i> proteins in a sample of the Spanish adult population in 2008\u20132013. Helicobacter. 2017;22:e12401.","DOI":"10.1111\/hel.12401"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tian W, Jia Y, Yuan K, et al. Serum antibody against <i>Helicobacter pylori<\/i> flaA and risk of gastric cancer. Helicobacter. 2014;19:9-16.","DOI":"10.1111\/hel.12095"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Filomena A, Guenther A, Planatscher H, et al. Performance of a multiplex serological <i>Helicobacter pylori<\/i> assay on a novel microfluidic assay platform. Proteomes. 2017;5:24.","DOI":"10.3390\/proteomes5040024"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311-1315.","DOI":"10.1016\/S0140-6736(84)91816-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Romagnani S. Th1\/Th2 cells. Inflamm Bowel Dis. 1999;5:285-294.","DOI":"10.1097\/00054725-199911000-00009"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Han M, Hu R, Ma J, et al. Fas signaling in dendritic cells mediates Th2 polarization in HDM-induced allergic pulmonary inflammation. Front Immunol. 2018;9:3045.","DOI":"10.3389\/fimmu.2018.03045"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Roved J, Westerdahl H, Hasselquist D. Sex differences in immune responses: hormonal effects, antagonistic selection, and evolutionary consequences. Horm Behav. 2017;88:95-105.","DOI":"10.1016\/j.yhbeh.2016.11.017"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mohammadi M, Nedrud J, Redline R, et al. Murine CD4 T-cell response to <i>Helicobacter<\/i> infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology. 1997;113:1848-1857.","DOI":"10.1016\/S0016-5085(97)70004-0"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Mohammad N, Karsabet MT, Amani J, et al. In silico design of a chimeric protein containing antigenic fragments of <i>Helicobacter pylori<\/i>; a bioinformatic approach. Open Microbiol J. 2016;10:97-112.","DOI":"10.2174\/1874285801610010097"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ghasemi A, Mohammad N, Mautner J, et al. Immunization with recombinant FliD confers protection against <i>Helicobacter pylori<\/i> infection in mice. Mol Immunol. 2018;94:176-182.","DOI":"10.1016\/j.molimm.2018.01.001"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/75\/5\/75_JJID.2021.795\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T04:52:51Z","timestamp":1663995171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/75\/5\/75_JJID.2021.795\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2021.795","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"article-number":"JJID.2021.795"}}